Trials / Terminated
TerminatedNCT01540669
Dose-Responsive Effect of Polydextrose on Whole Gut Transit Time
Dose-ranging Efficacy of 2-week Polydextrose Supplementation on Whole Gut Transit Time and Gastrointestinal Symptoms in Adults With Functional Constipation: A Double-blind, Randomized, Placebocontrolled Trial
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- Danisco · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to test the effect of polydextrose on whole gut transit time and gastrointestinal symptoms in a dose-responsive manner.
Detailed description
Given the promising, yet largely unsubstantiated, benefits of fiber supplementation, particularly polydextrose, on symptoms of functional constipation, the objective of this clinical trial is to evaluate the safety and effectiveness of 2-week supplementation of a proprietary polydextrose fiber product, in a dose-ranging fashion, on whole gut transit time and gastrointestinal symptoms in adults with functional constipation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Polydextrose, low dose | 4g polydextrose powder will be mixed with beverage and consumed once per day for 2 weeks |
| DIETARY_SUPPLEMENT | Polydextrose, medium dose | 8g polydextrose powder will be mixed with beverage and consumed once per day for 2 weeks |
| DIETARY_SUPPLEMENT | Polydextrose, high dose | 12g polydextrose powder will be mixed with beverage and consumed once per day for 2 weeks |
| DIETARY_SUPPLEMENT | Placebo powder | Placebo powder will be mixed with beverage and consumed once per day for 2 weeks |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2012-02-29
- Last updated
- 2016-01-22
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01540669. Inclusion in this directory is not an endorsement.